PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
8.7K / 3.59M (Avg.)
-1.55 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-8.77
Negative P/E while CRN.AX shows 9.96. Joel Greenblatt would examine path to profitability versus competitor.
1.45
P/S 50-75% of CRN.AX's 2.32. Bruce Berkowitz would examine if sales quality justifies the gap.
6.16
P/B above 1.5x CRN.AX's 1.07. Michael Burry would check for potential asset overvaluation.
-32.48
Negative FCF while CRN.AX shows P/FCF of 27.17. Joel Greenblatt would examine cash flow improvement potential.
4.73
P/OCF less than half of CRN.AX's 14.83. David Dodd would verify if operating efficiency justifies this discount.
6.16
Fair value ratio above 1.5x CRN.AX's 1.07. Michael Burry would check for mean reversion risks.
-2.85%
Negative earnings while CRN.AX shows yield of 2.51%. Joel Greenblatt would examine path to profitability.
-3.08%
Negative FCF while CRN.AX shows yield of 3.68%. Joel Greenblatt would examine cash flow improvement potential.